Sutro Biopharma, Inc.
STRO
$0.8578
$0.01021.20%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -17.61% | -21.43% | -18.38% | -8.86% | 36.00% |
Total Receivables | -41.02% | 57.40% | 29.47% | -4.24% | -77.80% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -25.63% | 39.76% | 63.74% | 3.20% | 4.66% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -19.41% | -16.28% | -15.39% | -8.50% | 25.07% |
|
|||||
Total Current Assets | -19.41% | -16.28% | -15.39% | -8.50% | 25.07% |
Net Property, Plant & Equipment | -9.86% | -7.78% | -5.67% | -4.33% | -5.87% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -3.71% | -88.26% | 0.01% | 37.93% | -11.75% |
Total Assets | -18.38% | -16.99% | -14.30% | -7.61% | 21.23% |
|
|||||
Total Accounts Payable | -47.33% | -21.91% | 68.52% | 2.14% | -18.97% |
Total Accrued Expenses | 47.01% | -15.39% | -4.08% | 6.15% | 50.13% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.76% | 3.81% | 3.85% | 3.89% | 3.90% |
Total Finance Division Other Current Liabilities | -85.61% | 12.65% | -2.93% | -1.96% | 98.48% |
Total Other Current Liabilities | -85.61% | 12.65% | -2.93% | -1.96% | 98.48% |
Total Current Liabilities | -44.20% | 0.87% | 0.46% | 1.00% | 63.48% |
|
|||||
Total Current Liabilities | -44.20% | 0.87% | 0.46% | 1.00% | 63.48% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -15.38% | -13.03% | -11.25% | -9.86% | -8.43% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 4.05% | 2.83% | 1.76% | 2.33% | -8.40% |
Total Liabilities | -15.20% | 1.35% | 0.59% | 1.11% | 10.31% |
|
|||||
Common Stock & APIC | 0.62% | 0.67% | 0.71% | 0.92% | 14.28% |
Retained Earnings | -1.33% | -9.65% | -10.14% | -7.33% | -7.77% |
Treasury Stock & Other | -44.44% | -123.08% | -63.21% | 165.03% | -44.25% |
Total Common Equity | -24.41% | -157.87% | -59.90% | -26.91% | 55.24% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -24.41% | -157.87% | -59.90% | -26.91% | 55.24% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -24.41% | -157.87% | -59.90% | -26.91% | 55.24% |
|